Ukrainian health-tech SME fabricating nanostructured surfaces for dental implants and photonic cancer-detection biosensors via electrospinning, ALD, and laser structuring.
CSD Health Care is a Ukrainian health-technology SME based in Kyiv specializing in nanostructured material fabrication and surface engineering for biomedical applications. Their laboratory work centers on producing and characterizing metal oxide and metal alloy nanostructures using techniques including electrospinning, atomic layer deposition (ALD), sol-gel processing, and laser-induced surface patterning. They apply these capabilities to two distinct medical domains: photonic biosensors for early cancer cell detection and nanostructured surface coatings for dental implants that promote osseointegration. As an MSCA-RISE participant, they contribute hands-on nanofabrication expertise to international research consortia through structured staff exchanges.
Electrospinning appears as a core technique in both CanBioSe and NanoSurf, alongside ALD and sol-gel, indicating these are established laboratory capabilities rather than peripheral contributions.
NanoSurf (EUR 31,500) focused entirely on nanostructural surface development for dental implant manufacturing, covering zirconium-titanium alloys, laser-induced periodic surface structures, and osseointegration metrics.
CanBioSe (EUR 27,000) targeted novel 1D photonic metal oxide nanostructures specifically for early-stage cancer cell detection using optical characterization methods.
NanoSurf keywords include LIPSS (laser-induced periodic surface structures) and nanopatterning, indicating expertise in precision laser-based surface modification for biomaterial applications.
Both projects launched simultaneously in 2018, so the keyword shift reflects two parallel application tracks rather than a strict chronological pivot. The CanBioSe work represents the sensing and diagnostics side — 1D metal oxide nanostructures, ALD, optical detection — while NanoSurf pushed into implant materials, bringing in zirconium-titanium alloys, sol-gel coatings, and laser surface structuring for osseointegration. Read together, the trajectory suggests that their core nanofabrication platform (electrospinning, surface modification) is being applied progressively toward more clinically embedded medical device contexts, with implantology and dental surgery emerging as the more commercially specific focus.
Their transferable nanofabrication toolkit — electrospinning, ALD, sol-gel, laser patterning — positions them to expand into other implantable medical device sectors such as orthopedic coatings, biosensor platforms, or antimicrobial surface treatments.
CSD Health Care participates exclusively as a consortium partner, never as coordinator, which is typical of a specialist SME that contributes defined laboratory capabilities to larger international networks. Both participations are within MSCA-RISE schemes, which involve rotating staff exchanges across multiple institutions rather than deep bilateral partnerships — meaning they are accustomed to working in fluid, multi-partner environments. With 19 unique partners across 10 countries from just two projects, they generate a disproportionately broad network relative to their size, suggesting they are active and engaged participants rather than passive recipients of consortium membership.
From only two projects, CSD Health Care has worked with 19 unique consortium partners spanning 10 countries, a notably wide reach for a small Ukrainian SME — a direct result of the MSCA-RISE format, which distributes staff exchanges across many partner institutions. Their network likely extends across Central and Eastern Europe, with connections to Western European research universities and institutes involved in nanomaterials and biomedical engineering.
CSD Health Care is among the very few Ukrainian private health-tech SMEs with verifiable H2020 participation in nanotechnology and biomedical surface engineering, offering Eastern European laboratory capacity to international consortia at competitive cost. Their dual competence in photonic cancer biosensors and dental implant coatings is an uncommon combination that bridges diagnostics and therapeutic device manufacturing within a single nanofabrication skill set. For consortia building around biomaterial surface engineering or medical diagnostics, they bring MSCA-validated international collaboration experience and a specific technical niche that larger institutes rarely fill as a dedicated SME partner.
